ZERIA PHARMACEUTICAL CO., LTD.
ゼリア新薬工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4559
FY2025 · 2026-03-31
| Gross margin | 73.1% |
| Operating margin | 13.9% |
| Net margin | 9.5% |
| Return on equity | 11.5% |
| Return on assets | 4.7% |
| Revenue growth (YoY) | 2.1% |
| EPS (basic) | ¥191.8 |
| EPS growth (YoY) | -14.9% |
| Current ratio | 1.48x |
| Equity ratio | 40.9% |
| Book value / share | ¥2,459.12 |
| Free cash flow | 7,595 M |